Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 956


Differential regulation of Bax and Bak by anti-apoptotic Bcl-2 family proteins Bcl-B and Mcl-1.

Zhai D, Jin C, Huang Z, Satterthwait AC, Reed JC.

J Biol Chem. 2008 Apr 11;283(15):9580-6. doi: 10.1074/jbc.M708426200. Epub 2008 Jan 4.


The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.

Kazi A, Sun J, Doi K, Sung SS, Takahashi Y, Yin H, Rodriguez JM, Becerril J, Berndt N, Hamilton AD, Wang HG, Sebti SM.

J Biol Chem. 2011 Mar 18;286(11):9382-92. doi: 10.1074/jbc.M110.203638. Epub 2010 Dec 9.


MCL-1 inhibits BAX in the absence of MCL-1/BAX Interaction.

Germain M, Milburn J, Duronio V.

J Biol Chem. 2008 Mar 7;283(10):6384-92. Epub 2007 Dec 18.


Characterization of the anti-apoptotic mechanism of Bcl-B.

Zhai D, Ke N, Zhang H, Ladror U, Joseph M, Eichinger A, Godzik A, Ng SC, Reed JC.

Biochem J. 2003 Nov 15;376(Pt 1):229-36.


Differential effects of anti-apoptotic Bcl-2 family members Mcl-1, Bcl-2, and Bcl-xL on celecoxib-induced apoptosis.

Rudner J, Elsaesser SJ, Müller AC, Belka C, Jendrossek V.

Biochem Pharmacol. 2010 Jan 1;79(1):10-20. doi: 10.1016/j.bcp.2009.07.021. Epub 2009 Aug 7.


Mitochondrial membrane permeabilisation by Bax/Bak.

Degli Esposti M, Dive C.

Biochem Biophys Res Commun. 2003 May 9;304(3):455-61. Review.


The multidomain proapoptotic molecules Bax and Bak are directly activated by heat.

Pagliari LJ, Kuwana T, Bonzon C, Newmeyer DD, Tu S, Beere HM, Green DR.

Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17975-80. Epub 2005 Dec 5.


Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis.

Nechushtan A, Smith CL, Lamensdorf I, Yoon SH, Youle RJ.

J Cell Biol. 2001 Jun 11;153(6):1265-76.


Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.

Olejniczak SH, Hernandez-Ilizaliturri FJ, Clements JL, Czuczman MS.

Clin Cancer Res. 2008 Mar 1;14(5):1550-60. doi: 10.1158/1078-0432.CCR-07-1255.


Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC.

Blood. 1998 May 1;91(9):3379-89.


Enhanced killing of melanoma cells by simultaneously targeting Mcl-1 and NOXA.

Qin JZ, Xin H, Sitailo LA, Denning MF, Nickoloff BJ.

Cancer Res. 2006 Oct 1;66(19):9636-45.


A putative role for human BFK in DNA damage-induced apoptosis.

Ozören N, Inohara N, Núñez G.

Biotechnol J. 2009 Jul;4(7):1046-54. doi: 10.1002/biot.200900091.


Expression of bcl-2 family members in malignant pleural mesothelioma.

O'Kane SL, Pound RJ, Campbell A, Chaudhuri N, Lind MJ, Cawkwell L.

Acta Oncol. 2006;45(4):449-53.


In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.

Rochaix P, Krajewski S, Reed JC, Bonnet F, Voigt JJ, Brousset P.

J Pathol. 1999 Mar;187(4):410-5.


Bak but not Bax is essential for Bcl-xS-induced apoptosis.

Lindenboim L, Kringel S, Braun T, Borner C, Stein R.

Cell Death Differ. 2005 Jul;12(7):713-23.


Mcl-1 determines the Bax dependency of Nbk/Bik-induced apoptosis.

Gillissen B, Essmann F, Hemmati PG, Richter A, Richter A, Oztop I, Chinnadurai G, Dörken B, Daniel PT.

J Cell Biol. 2007 Nov 19;179(4):701-15.


Dimerization properties of human BAD. Identification of a BH-3 domain and analysis of its binding to mutant BCL-2 and BCL-XL proteins.

Ottilie S, Diaz JL, Horne W, Chang J, Wang Y, Wilson G, Chang S, Weeks S, Fritz LC, Oltersdorf T.

J Biol Chem. 1997 Dec 5;272(49):30866-72.

Supplemental Content

Support Center